Evidence map›Paper›PMID 25472963›Full record

ArticleAmerican journal of physiology. Cell physiology2015

Krüppel-like factor KLF10 regulates transforming growth factor receptor II expression and TGF-β signaling in CD8+ T lymphocytes.

Konstantinos A Papadakis, James Krempski, Jesse Reiter, Phyllis Svingen, Yuning Xiong, Olga F Sarmento, April Huseby, Aaron J Johnson, Gwen A Lomberk, Raul A Urrutia and 1 more

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. New Insights into the Role of KLF10 in Tissue Fibrosis.International journal of molecular sciences · 2024
    Review
  8. Article
  9. Article
  10. ceRNA analysis of SARS-CoV-2.Archives of virology · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Functional validation reveals the novel missense V419L variant inCold Spring Harbor molecular case studies · 2017
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Konstantinos A PapadakisDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota;
James KrempskiDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota;
Jesse ReiterDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota;
Phyllis SvingenDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota;
Yuning XiongDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota;
Olga F SarmentoDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota;
April HusebyDivision of Immunology and Neurology, Mayo Clinic, Rochester, Minnesota; and.
Aaron J JohnsonDivision of Immunology and Neurology, Mayo Clinic, Rochester, Minnesota; and.
Gwen A LomberkEpigenetics and Chromatin Dynamics Laboratory, Departments of Medicine and Biochemistry and Molecular Biology, Epigenetic Translational Program, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota.
Raul A UrrutiaEpigenetics and Chromatin Dynamics Laboratory, Departments of Medicine and Biochemistry and Molecular Biology, Epigenetic Translational Program, Center for Individualized Medicine, Mayo Clinic, Rochester, Minnesota.
William A FaubionDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota; faubion.william@mayo.edu.
Mayo Clinic · USWinnMed · US

Funding

Targeted MV-CEA as a Potent Antitumor Agent against GBMP50CA108961 · NCI · MAYO CLINIC ROCHESTER · PI O'NEILL, BRIAN PATRICK · 2004 to 2015
$22.5M
PILOT AND FEASIBILTY PROGRAMP30DK084567 · NIDDK · MAYO CLINIC ROCHESTER · PI GREGORY J. GORES · 2009 to 2026
$22.2M
ZINC FINGER GENES AND PANCREATIC CELL GROWTHR01DK052913 · NIDDK · MEDICAL COLLEGE OF WISCONSIN · PI LOMBERK, GWEN, URRUTIA, RAUL A. · 1998 to 2023
$7.0M
KLF10 regulates colitis through mediating TGFb induction of FOXP3 in Treg cells.R01AI089714 · NIAID · MAYO CLINIC ROCHESTER · PI FAUBION, WILLIAM A · 2011 to 2025
$6.3M
CD 8 T Cell Mediated Disruption of Blood Brain Tight JunctionR01NS060881 · NINDS · UNIVERSITY OF CINCINNATI · PI JOHNSON, AARON J · 2009 to 2013
$1.7M
The Role of Zinc Finger Genes in Pancreatic Cell GrowthR56DK052913 · NIDDK · MAYO CLINIC ROCHESTER · PI URRUTIA, RAUL A. · 2008 to 2008
$291k
NCI NIH HHS P50 CA108961NIAID NIH HHS R01 AI-089714NIDDK NIH HHS DK-52913NIDDK NIH HHS P30 DK-084567NIDDK NIH HHS P30 DK084567NIDDK NIH HHS R01 DK052913NINDS NIH HHS NS-060881
6 · The paper itself

Abstract

KLF10 has recently elicited significant attention as a transcriptional regulator of transforming growth factor-β1 (TGF-β1) signaling in CD4(+) T cells. In the current study, we demonstrate a novel role for KLF10 in the regulation of TGF-β receptor II (TGF-βRII) expression with functional relevance in antiviral immune response. Specifically, we show that KLF10-deficient mice have an increased number of effector/memory CD8(+) T cells, display higher levels of the T helper type 1 cell-associated transcription factor T-bet, and produce more IFN-γ following in vitro stimulation. In addition, KLF10(-/-) CD8(+) T cells show enhanced proliferation in vitro and homeostatic proliferation in vivo. Freshly isolated CD8(+) T cells from the spleen of adult mice express lower levels of surface TGF-βRII (TβRII). Congruently, in vitro activation of KLF10-deficient CD8(+) T cells upregulate TGF-βRII to a lesser extent compared with wild-type (WT) CD8(+) T cells, which results in attenuated Smad2 phosphorylation following TGF-β1 stimulation compared with WT CD8(+) T cells. Moreover, we demonstrate that KLF10 directly binds to the TGF-βRII promoter in T cells, leading to enhanced gene expression. In vivo viral infection with Daniel's strain Theiler's murine encephalomyelitis virus (TMEV) also led to lower expression of TGF-βRII among viral-specific KLF10(-/-) CD8(+) T cells and a higher percentage of IFN-γ-producing CD8(+) T cells in the spleen. Collectively, our data reveal a critical role for KLF10 in the transcriptional activation of TGF-βRII in CD8(+) T cells. Thus, KLF10 regulation of TGF-βRII in this cell subset may likely play a critical role in viral and tumor immune responses for which the integrity of the TGF-β1/TGF-βRII signaling pathway is crucial.

Indexed as

AnimalsCD8-Positive T-LymphocytesCells, CulturedEarly Growth Response Transcription FactorsGene Expression RegulationHumansJurkat CellsKruppel-Like Transcription FactorsMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutMice, TransgenicProtein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type IIEarly Growth Response Transcription FactorsKLF10 protein, mouseKruppel-Like Transcription FactorsProtein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type IITransforming Growth Factor betaKLF10Krüppel-like factorTGF-β receptor IIT regulatory cell

Identifiers

PMID25472963
PMCPMC4346734
OpenAlexW2105122345

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.